Literature DB >> 23856334

Protein aggregation propensity is a crucial determinant of intracellular inclusion formation and quality control degradation.

Anna Villar-Piqué1, Salvador Ventura2.   

Abstract

Protein aggregation is linked to many pathological conditions, including several neurodegenerative diseases. The aggregation propensities of proteins are thought to be controlled to a large extent by the physicochemical properties encoded in the primary sequence. We have previously exploited a set of amyloid β peptide (Aβ42) variants exhibiting a continuous gradient of intrinsic aggregation propensities to demonstrate that this rule applies in vivo in bacteria. In the present work we have characterized the behavior of these Aβ42 mutants when expressed in yeast. In contrast to bacteria, the intrinsic aggregation propensity is gated by yeast, in such a way that this property correlates with the formation of intracellular inclusions only above a specific aggregation threshold. Proteins displaying solubility levels above this threshold escape the inclusion formation pathway. In addition, the most aggregation-prone variants are selectively cleared by the yeast quality control degradation machinery. Thus, both inclusion formation and proteolysis target the same aggregation-prone variants and cooperate to minimize the presence of these potentially dangerous species in the cytosol. The demonstration that sorting to these pathways in eukaryotes is strongly influenced by protein primary sequence should facilitate the development of rational approaches to predict and hopefully prevent in vivo protein deposition.
© 2013.

Entities:  

Keywords:  42 residue-length amyloid β peptide; AD; ATG1; Alzheimer's disease; Amyloid peptide; Aβ42; CHC; DMSO; EtOH; Fluorescent reporter; GFP; HD; Huntington's disease; PD; PMSF; PQC; Parkinson's disease; Protein aggregation; Protein degradation; Protein folding; SC-URA; Yeast; autophagy-specific gene 1; central hydrophobic cluster; cfu; colony-forming units; dimethyl sulfoxide; ethanol; green fluorescent protein; phenylmethanesulfonyl fluoride; protein quality control machinery; synthetic complete medium deficient for uracil

Mesh:

Substances:

Year:  2013        PMID: 23856334     DOI: 10.1016/j.bbamcr.2013.06.023

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Evaluation of the Impact of Protein Aggregation on Cellular Oxidative Stress in Yeast.

Authors:  Anita Carija; Salvador Ventura; Susanna Navarro
Journal:  J Vis Exp       Date:  2018-06-23       Impact factor: 1.355

2.  Proteome response at the edge of protein aggregation.

Authors:  Natalia Sanchez de Groot; Ricardo A Gomes; Anna Villar-Pique; M Madan Babu; Ana Varela Coelho; Salvador Ventura
Journal:  Open Biol       Date:  2015-02       Impact factor: 6.411

3.  Protein aggregation into insoluble deposits protects from oxidative stress.

Authors:  Anita Carija; Susanna Navarro; Natalia Sanchez de Groot; Salvador Ventura
Journal:  Redox Biol       Date:  2017-04-04       Impact factor: 11.799

4.  The fitness cost and benefit of phase-separated protein deposits.

Authors:  Natalia Sanchez de Groot; Marc Torrent Burgas; Charles Nj Ravarani; Ala Trusina; Salvador Ventura; M Madan Babu
Journal:  Mol Syst Biol       Date:  2019-04-08       Impact factor: 11.429

5.  Genome-wide analysis of Saccharomyces cerevisiae identifies cellular processes affecting intracellular aggregation of Alzheimer's amyloid-β42: importance of lipid homeostasis.

Authors:  S Nair; M Traini; I W Dawes; G G Perrone
Journal:  Mol Biol Cell       Date:  2014-05-28       Impact factor: 4.138

6.  Mammalian prion protein (PrP) forms conformationally different amyloid intracellular aggregates in bacteria.

Authors:  Bruno Macedo; Ricardo Sant'Anna; Susanna Navarro; Yraima Cordeiro; Salvador Ventura
Journal:  Microb Cell Fact       Date:  2015-11-04       Impact factor: 5.328

7.  Chaperone AMPylation modulates aggregation and toxicity of neurodegenerative disease-associated polypeptides.

Authors:  Matthias C Truttmann; David Pincus; Hidde L Ploegh
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-14       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.